Related references
Note: Only part of the references are listed.Molecular classification of breast carcinomas with particular emphasis on basal-like carcinoma: A critical review
Mohammad Ali Lavasani et al.
JOURNAL OF BIOPHOTONICS (2012)
Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast
Yurdanur Sullu et al.
PATHOLOGY RESEARCH AND PRACTICE (2011)
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
H. Raza Ali et al.
BREAST CANCER RESEARCH (2011)
Management of small HER2-positive breast cancers
Susana Banerjee et al.
LANCET ONCOLOGY (2010)
Activity of MMP-2 and MMP-9 in sera of breast cancer patients
Sandra Stankovic et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
Dimitra Bourboulia et al.
SEMINARS IN CANCER BIOLOGY (2010)
Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer
PS Patel et al.
INDIAN JOURNAL OF CANCER (2009)
Histological and molecular types of breast cancer: is there a unifying taxonomy?
Britta Weigelt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Triple negative tumours: a critical review
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival
Laura G. Fulford et al.
BREAST CANCER RESEARCH (2007)
MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors
D. C. Jinga et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Role of matrix metalloproteinases in melanoma cell invasion
UB Hofmann et al.
BIOCHIMIE (2005)
Integrin signalling during tumour progression
WJ Guo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with special reference to activator protein-2, HER2, and prognosis
JM Pellikainen et al.
CLINICAL CANCER RESEARCH (2004)
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma
HC Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Expression of luminal and basal cytokeratins in human breast carcinoma
DMA El-Rehim et al.
JOURNAL OF PATHOLOGY (2004)
Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
A Talvensaari-Mattila et al.
BRITISH JOURNAL OF CANCER (2003)
Matrix metalloproteinase-2 (MMP-2) in T1-2N0 breast carcinoma
R Hirvonen et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Matrix-directed regulation of pericellular proteolysis and tumor progression
W Hornebeck et al.
SEMINARS IN CANCER BIOLOGY (2002)
Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy
A Talvensaari-Mattila et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Share Paper
